Anupriya Aggarwal, Alberto Ospina Stella, Gregory Walker, Anouschka Akerman, Camille Esneau, Vanessa Milogiannakis, Deborah L Burnett, Samantha McAllery, Mariana Ruiz Silva, Yonghui Lu, Charles S P Foster, Fabienne Brilot, Aleha Pillay, Sabastiaan Van Hal, Vennila Mathivanan, Christina Fichter, Andrea Kindinger, Alexandra Carey Hoppe, Mee Ling Munier, Supavadee Amatayakul-Chantler, Nathan Roth, Germano Coppola, Geoff P Symonds, Peter Schofield, Jennifer Jackson, Helen Lenthall, Jake Y Henry, Ohan Mazigi, Hans-Martin Jäck, Miles P Davenport, David R Darley, Gail V Matthews, David S Khoury, Deborah Cromer, Christopher C Goodnow, Daniel Christ, Roselle Robosa, Damien J Starck, Nathan W Bartlett, William D Rawlinson, Anthony D Kelleher, Stuart G Turville
Genetically distinct variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have emerged since the start of the COVID-19 pandemic. Over this period, we developed a rapid platform (R-20) for viral isolation and characterization using primary remnant diagnostic swabs. This, combined with quarantine testing and genomics surveillance, enabled the rapid isolation and characterization of all major SARS-CoV-2 variants circulating in Australia in 2021. Our platform facilitated viral variant isolation, rapid resolution of variant fitness using nasopharyngeal swabs and ranking of evasion of neutralizing antibodies...
June 2022: Nature Microbiology